ABSTRACT
Inflammatory bowel disease (IBD) is a generic term that refers to Crohn's disease and ulcerative colitis. Crohn's disease (CD) is a granulomatous enteritis which can involve the ileum, colon, and other parts of the intestinal tract. The serologic responses seen in Crohn's disease include antibodies to Saccharomyces cerevisiae, mycobacteria, bacteroides, listeria and E. coli. Many of these organisms may be involved in the pathogenesis of the Crohn's disease. Ulcerative colitis is characterized by inflammation of the mucosa and submucosa of the large intestine. The CD and UC are considered to be distinct forms of IBD; however, there is a subgroup of CD with a UC-like presentation. In recent years, several serologic markers have been found to be useful for the diagnosis and differentiation of CD and UC. These markers include the following antibodies (a) 2pANCA, (b) ASCA, (c) pancreatic antibody, and (d) OmpC antibody. The application of a panel of markers with the use of an algorithm can identify specific subtypes of IBD that have different clinical courses and progression of the diseases. The application of the serologic markers is useful for diagnosis and management of CD and UC patients.
Subject(s)
Biomarkers , Inflammatory Bowel Diseases/diagnosis , Antibodies, Antineutrophil Cytoplasmic/blood , Education, Continuing , Fluorescent Antibody Technique, Indirect , Humans , Inflammatory Bowel Diseases/classification , Inflammatory Bowel Diseases/immunology , United StatesABSTRACT
Treatment of mice with heat-killed (HK) Mycobacterium bovis BCG or 1- to 10-microm chitin particles (nonantigenic N-acetyl-D-glucosamine polymers) is known to induce innate immune responses, including gamma interferon (IFN-gamma) production, which plays a Th1 adjuvant role. However, HK BCG further induces prostaglandin E2-releasing spleen macrophages (Mphi) (PGE2-Mphi), which potentially inhibit Th1 adjuvant activities. We found that chitin particles did not induce PGE2-Mphi formation. To further assess whether chitin has Th1 adjuvant effects, interleukin-10 (IL-10)-knockout (KO) mice and their wild-type (WT, C57BL/6) controls were immunized with a 30-kDa MPB-59 mycobacterial protein mixed with chitin. Immunization with MPB-59 alone induced Th2 responses, characterized by increases in total serum immunoglobulin E (IgE) and specific serum IgG1 levels and spleen Th2 cells producing IL-4, IL-5, and IL-10. No IFN-gamma-producing spleen Th1 cells, specific serum IgG2a, or delayed-type hypersensitivity (DTH) footpad reactions were detected. On the other hand, chitin-MPB-59 immunization significantly increased spleen Th1 responses, DTH reaction, and serum IgG2a levels along with decreases of Th2 responses. The magnitude of these Th1 adjuvant effects was greater in IL-10-KO mice than in WT mice. In contrast, immunization with HK BCG-MPB-59 showed little or no Th1 adjuvant effect. These data indicate that chitin has a unique Th1 adjuvant effect on the development of Th1 immunity against a mycobacterial antigen. IL-10 down-regulates the adjuvant effect of chitin.
Subject(s)
Acetylglucosamine/immunology , Adjuvants, Immunologic , Antigens, Bacterial/immunology , Down-Regulation/immunology , Interleukin-10/immunology , Th1 Cells/immunology , Th2 Cells/immunology , Up-Regulation/immunology , Animals , Cells, Cultured , Chitin/immunology , Dinoprostone/immunology , Female , Hypersensitivity, Delayed/immunology , Immunoglobulin E/blood , Immunoglobulin G/blood , Interleukin-10/genetics , Macrophages, Alveolar/cytology , Macrophages, Alveolar/immunology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mycobacterium bovis/immunology , Polymers , Spleen/cytology , Spleen/immunologyABSTRACT
p62 is a RNA-binding protein that was isolated by immunoscreening a cDNA expression library with autoantibodies from patients with hepatocellular carcinoma (HCC). This autoantigen binds to mRNA encoding insulin-like growth factor II, which has been found to be overexpressed in HCC and is tumorigenic in transgenic animals. Immunohistochemical analysis of HCC liver showed that 33% (9 of 27) exhibited readily detectable staining of p62 protein in the cytoplasm of all malignant cells in cancer nodules, whereas it was undetectable in adjacent nonmalignant liver cells. In addition one of two patients with cholangiocarcinoma expressed p62 in malignant bile duct epithelial cells. p62 expression was also detected in scattered cells in cirrhotic nodules in contrast to uniform expression in all cells in HCC nodules. In HCC nodules, p62 mRNA was also detected by reverse transcriptase-polymerase chain reaction analysis. Nine normal adult livers did not contain detectable p62 mRNA or p62 protein whereas five fetal livers were all positive for mRNA and protein. The observations show that p62 is developmentally regulated, expressed in fetal, but not in adult liver, and aberrantly expressed in HCC and could be playing a role in abnormal cell proliferation in HCC and cirrhosis by modulating expression of growth factors such as insulin-like growth factor II.
Subject(s)
Carcinoma, Hepatocellular/metabolism , Fetus/metabolism , Liver Cirrhosis/metabolism , Liver Neoplasms/metabolism , RNA-Binding Proteins/metabolism , Adult , Aged , Aged, 80 and over , Bile Ducts/metabolism , Carcinoma, Hepatocellular/pathology , Cholangiocarcinoma/metabolism , Cholangiocarcinoma/pathology , Epithelial Cells/physiology , Female , Gene Expression , Hepatocytes/metabolism , Humans , Liver/metabolism , Liver Neoplasms/pathology , Male , Middle Aged , RNA, Messenger/metabolism , RNA-Binding Proteins/geneticsABSTRACT
The mycobacterial antigen MPB-64 was formulated for delivery in a transdermal patch and used as a diagnostic skin test reagent to detect active tuberculosis (TB) in patients attending a clinic in Manila, The Philippines. The MPB-64 Transdermal Patch was applied to 62 patients, 49 with sputum-positive active disease and 13 who had completed TB chemotherapy, and to 28 non-TB but tuberculin-positive controls. The results were read at 72 h. The sensitivity of the Transdermal Patch was 87.8%, with an efficacy of 92.9% and a specificity of 100%. The 13 TB patients who had completed 6 months of TB chemotherapy showed different reactions to the MPB64 patch test: those who had completed chemotherapy < 4 months before testing were positive; 50% of patients who completed chemotherapy 5 months previously were positive; and those who had completed chemotherapy 7 and 8 months before were negative. All the non-TB controls with positive tuberculin tests were negative to the MPB-64 Transdermal Patch, even at the highest protein dose tested. This test may be a useful method to distinguish active TB patients from TB-infected but asymptomatic individuals. Moreover, the MPB64 Transdermal Patch may be useful to monitor successful chemotherapy.
Subject(s)
Antigens, Bacterial , Bacterial Proteins , Patch Tests , Tuberculosis/diagnosis , Case-Control Studies , Diagnosis, Differential , Humans , Patch Tests/methods , Sensitivity and Specificity , Time Factors , Tuberculin Test , Tuberculosis/drug therapy , Tuberculosis/microbiologyABSTRACT
Helicobacter pylori is a highly motile bacterium with multiple unipolar flagella, and it produces the urease enzyme. The flagella and urease are the virulence factors of H. pylori. H. pylori often establishes a chronic infection in the stomach that may lead to gastric and duodenal ulcers, gastric cancers, gastric lymphomas, and other gastrointestinal diseases. There are several different invasive and noninvasive clinical laboratory tests for H. pylori. Laboratory testing is not indicated in asymptomatic patients and should be considered only if treatment of H. pylori infection is planned. Invasive tests for H. pylori, such as tissue histology, culture, and rapid urease tests, are used if an endoscopy is performed on the patient. The noninvasive tests for H. pylori, such as enzyme antibody and urea breath tests, are recommended in patients whose symptoms do not warrant endoscopy. The urea breath test is very useful and is recommended to evaluate effectiveness in the eradication and treatment of H. pylori infections. Nucleic acid tests can complement other diagnostic procedures, and are useful in evaluating fixed biopsy tissue, environmental samples, gastric juices, oral secretions, and stool samples.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Helicobacter Infections , Helicobacter pylori/isolation & purification , Child , Clinical Laboratory Techniques , Female , Helicobacter Infections/diagnosis , Helicobacter Infections/drug therapy , Helicobacter Infections/epidemiology , Helicobacter pylori/pathogenicity , Humans , Male , Polymerase Chain Reaction , PrevalenceABSTRACT
The Association of Medical Laboratory Immunologists (AMLI) have developed a panel of antinuclear and anticytoplasmic antibody consensus sera that can be useful for enzyme immunoassay (EIA), Ouchterlony, and immunofluorescence assay methods. It was developed to assist in the evaluation of newly available EIA methods for the detection of autoantibodies. The panel of sera was evaluated in several clinical laboratories and a large number of laboratories owned by manufacturers of clinical autoantibody testing kits. The majority of sera performed well for the EIAs in both the clinical laboratories and the manufacturers' laboratories, but some samples had discrepant results. A major source of discrepancy is the current inability of the EIA results to be directly compared in a quantitative way as no standardization exists. The evaluation demonstrated lower sensitivity of detection by the Ouchterlony method. The limited evaluation of the sera with immunoblotting and Western blotting did not show good agreement with other methods. Further work must be done to standardize blotting methods prior to their use in routine clinical testing. The sera are now available to vendors and clinical laboratories for use in the detection of SS-A, SS-B, Sm, U1-RNP, Scl-70, Jo-1, double-stranded DNA, and centromere antibodies. The availability of the consensus sera will help evaluate and improve the EIA methods currently being used.
Subject(s)
Antibodies, Antinuclear/analysis , Antibodies, Antinuclear/immunology , Immunoenzyme Techniques/standards , Laboratories/standards , Antibody Specificity , False Negative Reactions , False Positive Reactions , Humans , Immunoenzyme Techniques/methods , Reference Standards , Societies, Medical , World Health OrganizationABSTRACT
Rheumatoid arthritis (RA) is a chronic systemic inflammatory autoimmune disorder which is predominant in females. The exact etiology remains undefined. Recently, a large number of biochemical and biologic markers, which are useful in the diagnosis, prognosis, and monitoring therapy of RA, have been reported. The new markers include genetic markers, filaggrin, citrulline containing peptides, A2/RA33, cytokines, joint and collagen breakdown products, and bone turnover markers. No laboratory tests in and of themselves are diagnostic of RA. The new markers have been employed in monitoring RA patients during treatment and following the course of the disease. With the development of innovative therapies for RA, many of the biochemical and biologic markers will be useful.
Subject(s)
Arthritis, Rheumatoid/diagnosis , Biomarkers/analysis , Acute-Phase Proteins/analysis , Antibodies, Antinuclear/blood , Arthritis, Rheumatoid/genetics , Arthritis, Rheumatoid/therapy , Bone Remodeling , Collagen/metabolism , Cytokines/analysis , Filaggrin Proteins , Humans , Intermediate Filament Proteins/analysis , Intermediate Filament Proteins/immunology , Joints/metabolism , Prognosis , Rheumatoid Factor/bloodABSTRACT
This study investigates whether supplementation with topical RRR-alpha-tocopherol (Eol), topical RRR-alpha-tocopheryl succinate, and oral RRR-alpha-tocopheryl acetate can reduce the incidence of acute and chronic damage to the skin (i.e., sunburn and pigmentation and skin cancer, respectively) induced by ultraviolet (UV) irradiation to mice. Groups of twenty Skh:2 female hairless pigmented mice were treated with 1) lotion vehicle, 2) 5% Eol lotion, 3) 5% topical RRR-alpha-tocopheryl succinate lotion, or 4) lotion vehicle and oral RRR-alpha-tocopheryl acetate. Within each group, 15 mice were exposed to 0.24 J/cm2 of UV-B radiation three times per week. The animals' weights and food intakes were monitored, and the vitamin E concentrations of skin, liver, and adipose tissue were measured to determine whether the topical Eol resulted in significant tissue levels. Skin pigmentation was scored, and the total number of clinically detectable skin tumors per animal was counted weekly. Results showed that the skin concentrations of Eol, as well as levels in the adipose tissue, were increased after topical application. Mice treated with each form of vitamin E showed no signs of toxicity and had significantly less acute and chronic skin damage induced by UV irradiation, as indicated by reduced inflammation and pigmentation and by later onset and lesser incidence of skin cancer.
Subject(s)
Neoplasms, Radiation-Induced/prevention & control , Skin Neoplasms/prevention & control , Skin Pigmentation/drug effects , Ultraviolet Rays/adverse effects , Vitamin E/administration & dosage , Administration, Oral , Administration, Topical , Animals , Body Weight , Disease Models, Animal , Energy Intake , Female , Mice , Mice, Hairless , Neoplasms, Radiation-Induced/etiology , Skin Neoplasms/epidemiology , Skin Neoplasms/etiology , Skin Pigmentation/radiation effects , Tissue DistributionABSTRACT
Future trends in healthcare delivery will focus on preventive medicine that will require integration of molecular medicine with advanced information and computer technology. Molecular medicine will shift from costly intervention and treatment of established diseases to proactive prediction and prevention of disease risks. This approach will require new informatic systems that will link large scale databanks and special programs for data mining and retrieval in bioinformatics, cheminformatics, and population genetics. The clinical laboratory will soon be able to provide powerful new molecular diagnostic tools along with multianalytic assays for expression of genes and proteins in different patterns of diseases, disease progression, and predisposition to diseases.
Subject(s)
Biotechnology/trends , Delivery of Health Care/trends , Laboratories/trends , Clinical Laboratory Techniques/trends , Information SystemsABSTRACT
Protection of hosts against tuberculosis depends on expression of cellular immunity. To express cellular immunity, interleukin 12 (IL-12) has been shown to play an important role. Although Mycobacterium tuberculosis is known to induce IL-12 from macrophages (M phi s), the mechanism for the induction is still unclear. To understand the mechanisms of IL-12 induction from M phi s by M. tuberculosis, the IL -12-inducing ability of substances derived from M. tuberculosis was investigated in vitro. Production of IL-12 in culture medium of M phi s was measured by ELISA system using specific antibodies. Live M. tuberculosis H37Rv induced slightly higher IL-12 production than live M. tuberculosis H37Ra upon stimulation of human or mouse alveolar macrophages (hAM phi s or mAM phi s). Heat-killed M. tuberculosis failed to induce IL-12 production of alveolar macrophages (AM phi). The responses of hAM phi s and mAM phi s to M. tuberculosis were remarkably different. mAM phi s produced five times larger amount of IL-12, compared with that from hAM phi s. Human peripheral blood mononuclear cells (PBMC) obtained by the density gradient centrifugation were also used for induction of IL-12 production. Although production levels of IL-12 from PBMC stimulated with M. tuberculosis were below the detectable level, addition of interferon-gamma (IFN-gamma) or neutralizing antibody against IL-10 augmented the production of IL-12 from PBMC, suggesting that IFN-gamma and IL-10 regulate the production of IL-12 from M phi positively and negatively, respectively. To characterize the physicochemical properties of IL-12-inducing molecules, M. tuberculosis H37Rv was disrupted by pressing with 1,000 bar and centrifuged and separated into cytosol and cell wall fraction. The culture filtrate was also examined on IL-12-inducing activity. Among the three subjects examined, cytosol was found to induce the highest production of IL-12 from mAM phi s 1 day after the stimulation. Addition of IFN-gamma to the cytosol fraction markedly increased the production of IL-12 from mAM phi s. The molecular weight of IL-12-inducing substance was shown to be more than 30kDa by fractionating with molecular filters. Treatment of 30kDa-fraction with IL-12-inducing activity by proteinase K completely abolished the activity. Furthermore, approximately 90% of IL-12-inducing activity of 30kDa-fraction was lost by proteinase K treatment even in the presence of IFN-gamma. These results indicate that the major component of IL-12-inducing activity is a protein. The identification of this IL-12-inducing active substance may provide a new therapeutic tool for tuberculosis.
Subject(s)
Bacterial Proteins/pharmacology , Interleukin-12/biosynthesis , Macrophages, Alveolar/metabolism , Mycobacterium tuberculosis/chemistry , Animals , Bacterial Proteins/antagonists & inhibitors , Cells, Cultured , Endopeptidase K/pharmacology , Humans , Interferon-gamma/pharmacology , Interleukin-10/pharmacology , Leukocytes, Mononuclear/metabolism , Mice , Molecular Weight , Mycobacterium tuberculosis/cytology , Stimulation, ChemicalABSTRACT
In our study of the immunoregulatory roles of IL-10 in innate immunity, nonantigenic phagocytosable chitin particles were administered i.v. to IL-10-deficient (knockout (KO)) mice or KO mice pretreated with anti-NK1.1 or anti-IFN-gamma Abs. The results established that chitin treatment of KO mice increased superoxide anion release from alveolar macrophages (Mphi) to a level much higher than that in wild-type (WT) mice. The results also suggested that the NK cell is the source of IFN-gamma that is primarily responsible for this alveolar Mphi priming. To further study the roles of IL-10-inhibiting chitin-induced IFN-gamma production, we used spleen cell cultures. The experiments showed that IL-12, IL-18, and TNF-alpha, which were produced by chitin-stimulated Mphi, contributed to the IFN-gamma-inducing activity of chitin. Our results established that exogenous IL-10 inhibited chitin-induced IFN-gamma production in spleen cell cultures from both KO and WT mice. Exogenous IL-10 also inhibited IL-12 and TNF-alpha production by chitin-stimulated Mphi. Exogenous IL-10 decreased IL-12- or IL-18-induced IFN-gamma levels in KO but not in WT NK cell cultures. However, exogenous IL-10 enhanced IFN-gamma levels when NK cells were stimulated simultaneously with both IL-12 and IL-18 in KO and WT cultures. Our in vitro data indicate that IL-10 has differential effects on chitin-induced IFN-gamma production. However, the inhibitory effects of endogenous IL-10 appear to be dominant in the chitin-induced alveolar Mphi priming response in vivo.
Subject(s)
Chitin/immunology , Immunity, Cellular , Interleukin-10/immunology , Killer Cells, Natural/immunology , Macrophages/immunology , Animals , Interferon-gamma/immunology , Macrophage Activation/immunology , MiceABSTRACT
SETTING: A collaborative study between the Japan BCG Laboratory, Tokyo, Japan, and the Infectious Disease Section, Philippine General Hospital, Manila, the Philippines. Tuberculosis patients from four clinics in the vicinity of Manila, Our Lady of Grace Parish, Sto. Niño de Tondo Parish, the Canossa Health and Social Center, and the Health Care Development Center, were examined. OBJECTIVE: To develop a new, simple and rapid diagnostic method for active tuberculosis. Subjects were tested for skin reaction to a special antigen, MPB64, by the patch test method instead of intradermal injection of purified protein derivative (PPD). DESIGN: Fifty-three active tuberculosis patients and 43 healthy PPD-positive controls were tested to determine whether or not the reaction to MPB64 was positive only in active tuberculosis patients. RESULTS: Fifty-two of the 53 active tuberculosis patients showed a positive reaction to MPB64, while none of the 43 PPD-positive controls did. The specificity of MPB64 to active tuberculosis was 100%, and the sensitivity was 98.1%. The efficacy of the test was 98.9%. CONCLUSION: The patch test with MPB64 is a promising method for the diagnosis of active tuberculosis, distinguishing tuberculous patients from those who are infected but have not developed the disease, and also from BCG-vaccinated individuals. This new skin test is a subject for further evaluation and it is important to compare the results with PPD Mantoux.
Subject(s)
Antigens, Bacterial/analysis , Bacterial Proteins/analysis , Mycobacterium tuberculosis/isolation & purification , Tuberculin Test , Tuberculosis/diagnosis , Animals , Evaluation Studies as Topic , Female , Guinea Pigs , Humans , Male , Mycobacterium tuberculosis/immunology , Predictive Value of Tests , Sensitivity and Specificity , Tuberculin Test/methodsABSTRACT
Neuropsychiatric Systemic Lupus Erythematosus (NPSLE) can be defined as a significant and unequivocal change in the baseline neurologic and psychiatric function identified by history and physical examination. NPSLE can involve the central nervous system and/or the peripheral autonomic nervous system. This article reviews the clinical manifestations, pathology, and immunopathogenesis of NPSLE. The use and importance of diagnostic procedures including autoantibody assays in the evaluation of NPSLE are discussed.
Subject(s)
Autoantibodies , Lupus Erythematosus, Systemic/diagnosis , Nervous System Diseases/diagnosis , Autoantibodies/cerebrospinal fluid , Cerebrospinal Fluid Proteins , Diagnosis, Differential , Female , Humans , Lupus Erythematosus, Systemic/cerebrospinal fluid , Male , Nervous System Diseases/cerebrospinal fluid , Prospective StudiesABSTRACT
OBJECTIVES: We sought to determine the contribution of type 2 diabetes mellitus to mortality in a Navajo population, and to assess the impact of pre-existing coronary heart disease on this relationship. METHODS: A cohort of 77 Navajos with type 2 diabetes mellitus and 77 non-diabetic controls matched on age, gender and community of residence were followed for an 18-year period, from 1974 to 1992. RESULTS: The vital status of 152 of the 154 study subjects was ascertained at 18-year follow-up. There were 30 deaths (39%) in the type 2 diabetes group and 13 (17%) in the control group during the 18-year period which was significantly different in bivariate matched pairs analysis (risk ratio = 3.12, McNemar's chi 2 = 7.76, p < 0.01). Multivariate conditional logistic response models (risk ratio = 3.02, 95% CI 1.21, 7.53) and stratification analysis (McNemar's Summary chi 2 = 8.05, 2 df, p < 0.05), confirmed that survival was significantly different for the two groups, even when controlling for baseline cardiovascular comorbidity and hypertension. CONCLUSION: These data describe the mortality impact of the epidemic of type 2 diabetes and cardiovascular disease now accelerating among the Navajo. The significant mortality differences between the diabetes and non-diabetes groups and the continuing rise in prevalence of type 2 diabetes underscore the need for an effective community-based approach to diabetes prevention among the Navajo.
Subject(s)
Diabetes Mellitus, Type 2/ethnology , Indians, North American , Arizona/epidemiology , Cardiovascular Diseases/complications , Cardiovascular Diseases/ethnology , Cardiovascular Diseases/mortality , Case-Control Studies , Cohort Studies , Comorbidity , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/mortality , Female , Humans , Male , Matched-Pair Analysis , Middle Aged , Odds Ratio , RiskABSTRACT
This review discusses the current concepts of immunological tolerance, physiological vs. pathological autoimmunity, autoimmune diseases, and laboratory tests helpful in diagnosis. The autoantibodies in organ-specific autoimmune diseases are directed against antigens of the injured organs, whereas the antinuclear antibodies (ANA) detected in systemic autoimmune diseases are detected against a vast array of nuclear and intracellular antigens and peptides necessary for DNA/RNA synthesis, repair, splicing, and transcription. Knowledge of the mean titer and presence or absence of specific ANA types will help predict the nature of the disease and the response to therapy. Noteworthy features of these "ANA profiles" are (1) patients with systemic lupus erythematosus frequently have multiple types of ANA but anti-dsDNA and anti-SM are diagnostic, (2) patients with drug-induced lupus have ANA restricted to antihistone, (3) patients with mixed connective tissue disease have ANA restricted to anti-RNP, (4) patients with CREST (calcinosis, Raynaud's, esophageal dysmotility, sclerodactyly, and telangiectasia) syndrome have ANA restricted to anticentromere, (5) ANA with anti-SS-A/Ro specificity is associated with vasculitis and nephritis, (6) ANA with anti-SS-B/La and anti-nRNP specificities is associated with milder clinical disease, (7) ANAs with anti-Jo-1 and PM-Scl specificities are associated with pulmonary fibrosis and poor prognosis. Technological advances in the fields of molecular immunogenetics are guiding the studies of autoimmune diseases from serological and histopathological evaluations toward search for subcellular risk factors such as chemical and biological agents and susceptibility genes. Knowledge of these factors will help (1) to identify disease susceptibility genes prior to clinical onset and irreversible tissue damage, (2) to avoid environmental risk factors, and (3) to devise specific immunosuppressive strategies.
Subject(s)
Autoimmune Diseases/diagnosis , Autoimmune Diseases/immunology , Autoimmune Diseases/pathology , Autoimmunity/immunology , Humans , Immune Tolerance/immunology , Immunologic Tests/instrumentation , Immunologic Tests/methodsABSTRACT
Angiotensin II receptor levels have been shown to vary with postoperative time in tissue harvested from full-thickness dermal excisional wounds on adult rats. This study examined the expression of AII receptors in a sutured wound model. Two full-thickness incisional wounds were made in the dorsal skin of adult Sprague-Dawley rats and sutured immediately under general anesthesia. The wound tissues were harvested at 0, 0.5, 1, 2, 4, 24 h and on days 2, 3, 4, 5, 7, and 10 after the wounding. The levels of 125I-Sar1.Ile8-AII bound to membrane preparations of the wound tissues decreased at early time points (from 0.5 to 4 h), increased from day 1 to day 7, and returned to nonsurgical levels by day 10. Competitive binding studies showed that the receptors were predominantly of the AT1 receptor subtype. These results suggest that an immediate and transient reduction in AII receptor expression occurred after wounding, followed by an increase in the number of AII receptors that was maintained for 5 to 7 days postoperatively. Because these data are consistent with those observed after excisional wounding, temporal changes in AII receptor expression may be integral to the process of wound healing.
Subject(s)
Receptors, Angiotensin/metabolism , Skin/chemistry , Sutures , Wound Healing/physiology , 1-Sarcosine-8-Isoleucine Angiotensin II/metabolism , 1-Sarcosine-8-Isoleucine Angiotensin II/pharmacology , Animals , Binding, Competitive/physiology , Dermatologic Surgical Procedures , Enzyme Inhibitors/metabolism , Enzyme Inhibitors/pharmacology , Female , Iodine Radioisotopes , Postoperative Period , Rats , Rats, Sprague-Dawley , Receptors, Angiotensin/drug effects , Skin/metabolismABSTRACT
PCR-SSCP method to detect genetic mutations in rpoB gene as a marker of rifampicin-resistance was developed by Telenti et al., and we have modified it applying non-radioactive PhastSystem for more practical use in the detection of rifampicin-resistance of Mycobacterium tuberculosis. PCR products amplified with the primers specific to rpoB gene using extracted DNA from 89 strains of M. tuberculosis were sequenced and the amino acid sequences were morphism was determined by the PhastSystem. The bands were stained by silver staining. Among 89 strains of M. tuberculosis, 43 were confirmed as rifampicin-resistant (RFPr) and 46 were rifampicin-sensitive (RFPs) by the culture on the drug-containing media. All of the 43 RFPr strains had one or more mutations in the DNA sequence of rpoB gene, while none of the RFPs strains had such mutations. However, by PCR-SSCP, only 20 out of 43 RFPr strains showed clear differences in the band pattern of electrophoresis from that of RFPs strains. Other 23 RFPr strains had only slight differences in the band pattern of the PCR-SSCP from that of RFPs strains. But it was noticed that the main bands of RFPr strains were distinguishable from the main bands of RFPs strains even their patterns were similar. Thus, it is possible to apply a non-radioactive PCR-SSCP for the detection of rifampicin resistance of M. tuberculosis with further improvement of the condition of gel electrophoresis or staining techniques.
Subject(s)
Antibiotics, Antitubercular/pharmacology , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/isolation & purification , Rifampin/pharmacology , Amino Acid Sequence , Base Sequence , Drug Resistance, Microbial , Molecular Sequence Data , Polymerase Chain Reaction , Polymorphism, GeneticABSTRACT
Angiotensin II was recently shown to have a growth-promoting role after vascular injury and in the development of cardiac hypertrophy and fibrosis. In addition, angiotensin II may play a role in dermal wound repair. In this article, alterations in angiotensin II receptor levels in tissue harvested from full-thickness excisional dermal wounds in adult Sprague-Dawley rats were examined. A 2.25 cm(2) full-thickness excision of the dorsal skin was made under general anesthesia, and the tissue was harvested on days 1, 3, 5, 7, and 10 after wounding. The level of (125)I-Sar(1).IIe(8)-angiotensin II bound to membrane preparations of both granulation tissue and wound edge increased from day 1, peaked on day 5, and returned to nonsurgical levels by day 10. In both granulation and wound edge segments of the injured skin, the maximum binding on postoperative day 5 was about twice that of postoperative day 1 tissue or control skin. Competitive binding studies with angiotensin II type 1 receptor or type 2 receptor antagonists (DuP 753 and CGP 42112B, respectively) showed that the receptors present in the healing dermal tissue from the adult rat were almost entirely of the type 1 receptor form.
ABSTRACT
The cause of the female urethral syndrome has previously been obscure, as it has been associated by definition with a lack of objective findings but a plethora of subjective complaints of retropubic pressure, dyspareunia, urinary frequency, and dysuria. There is now strong evidence that the microscopic paraurethral glands connected to the distal third of the urethra in the prevaginal space are homologous to the prostate. They stain histologically for prostate-specific antigen and, like the prostate, are subject to both infection and cancer. The most important aspect of recognizing this microscopic "female prostate" as an anatomic feature is that its infections may completely explain many cases of the urethral syndrome. Further, the diagnosis is not elusive if trained clinicians palpate for localized and objective paraurethral tenderness through the anterior vagina wall to one or both sides of the urethra. Treatment parallel to that for male prostatitis is usually rewarded by the elimination of symptoms and the objective finding of the loss of tenderness of the paraurethral glands. As with prostatitis, the localized problem often recurs. It is time to alert primary care physicians to this disorder and to eliminate the widespread practice of treating affected women with either invasive urethral dilation or tranquilizers.